Emergent BioSolutions (EBS) Return on Equity [ROE] (2011 - 2026)
Emergent BioSolutions (EBS) recorded Return on Equity [ROE] of -40.90% in Q2 2026, down 66.52 percentage points from 25.62% a year earlier and down 39.26 percentage points from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Emergent BioSolutions reported Return on Equity [ROE] of 10.46%, up 44.14 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of -13.59 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -33.67% in FY2024 (+41.00 pp), -74.67% in FY2023 (-60.56 pp), -14.11% in FY2022 (-28.45 pp) and 14.34% in FY2021 (-9.72 pp).
- The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] since Q3 2024.
- On a year-over-year basis, Return on Equity [ROE] rose in seven of the last eight quarters, with an average year-over-year change of +48.18 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 137.41 percentage points in Q2 2025, against a drop of 97.77 percentage points in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -1.64% (Q1 2026), 9.52% (Q4 2025) and 13.57% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | - |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 4.97% |
| 10 | Emergent BioSolutions | 325.34 Mn | -425.56 Mn | 137.20 Mn | -40.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -40.90% |
| Mar 31, 2026 | -1.64% |
| Dec 31, 2025 | 9.52% |
| Sep 30, 2025 | 13.57% |
| Jun 30, 2025 | 25.62% |
| Mar 31, 2025 | -25.42% |
| Dec 31, 2024 | -38.46% |
| Sep 30, 2024 | -46.67% |
| Jun 30, 2024 | -111.79% |
| Mar 31, 2024 | -86.10% |
| Dec 31, 2023 | -112.96% |
| Sep 30, 2023 | -94.02% |
| Jun 30, 2023 | -55.67% |
| Mar 31, 2023 | -30.61% |
| Dec 31, 2022 | -15.19% |
| Sep 30, 2022 | 2.09% |
| Jun 30, 2022 | 5.53% |
| Mar 31, 2022 | 9.19% |
| Dec 31, 2021 | 14.01% |
| Sep 30, 2021 | 14.85% |
API Access
Emergent BioSolutions Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();